Evidence in Focus: The Sparse Landscape of Randomized Trials on Retinoblastoma Treatment
{{output}}
Background: Retinoblastoma, although rare, is one of the most common intraocular malignancies worldwide. Its prognosis has improved significantly in the past few decades, thanks to modern treatments, like systemic, intra-arterial... ...
